Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
One of the goals in the treatment for diabetes is to enhance pancreatic beta cell function, proliferation, and survival. This study explores the role of lactogenic hormones, prolactin (PRL) and placental lactogen (PL), in beta cell survival. We have previously shown that transgenic mice expressing mouse placental lactogen-1 (mPL1) in beta cells under the rat insulin II promoter (RIP) are resistant to the diabetogenic and cytotoxic effects of streptozotocin (STZ) in vivo. The current study demonstrates that lactogens protect rat insulinoma (INS-1) cells and primary mouse beta cells against two distinct beta cell death inducers, STZ and dexamethasone (DEX), in vitro. Further, we identify the mechanism through which lactogens protect beta cells against DEX-induced death. The signaling pathway mediating this protective effect is the janus-activated-kinase-2/signal transducer and activator of transcription-5 (JAK2/STAT5) pathway. This is demonstrated in INS-1 cells and primary mouse beta cells using three separate approaches, pharmacological inhibitors, JAK2-specific siRNAs and a dominant-negative STAT5 mutant. Furthermore, lactogens specifically and significantly increase the anti-apoptotic protein Bcl-XL in insulinoma cells and mouse islets. Bcl-XL-specific siRNA significantly inhibits lactogen-mediated protection against DEX-induced beta cell death. We believe this is the first direct demonstration of lactogens mediating their protective effect through the JAK2/STAT5 pathway in the beta cell and through Bcl-XL in any cell type.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [70]
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Davalli, A. M., Scaglia, L., Zangen, D. H., Hollister, J., Bonner-Weir, S., & Weir, G. C. (1996) · Diabetes · doi:10.2337/diab.45.9.1161 · Cited by 468
Brelje, T. C. (1993) · Endocrinology · doi:10.1210/en.132.2.879 · Cited by 408
Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K.-I., Watanabe, T., Sugimoto, T., Nakagama, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2301 · Cited by 286
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258
Vasavada, R. C., Garcia-Ocaña, A., Zawalich, W. S., Sorenson, R. L., Dann, P., Syed, M., Ogren, L., Talamantes, F., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15399 · Cited by 212
Self-citation
Research works printed but not linked: 3
- Talamantes, 1990, Prog. Clin. Biol. Res., 342, 81
- Biswas, 1987, Cancer Res., 47, 3509
- Vasavada, R. C., Wang, L., Fujinaka, Y., Takane, K. K., Rosa, T. C., Mellado-Gil, J. M., Friedman, P. A., and Garcia-Ocana, A. (2007) Diabetes, in press
Cited by
Placental hormones and the control of maternal metabolism and fetal growth
Newbern, D., & Freemark, M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834c800d · Cited by 487
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
BackgroundNatural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
Peptide Hormone Regulation of Angiogenesis
Clapp, C., Thebault, S., Jeziorski, M. C., & Martínez De La Escalera, G. (2009) · Physiological Reviews · doi:10.1152/physrev.00024.2009 · Cited by 191
“PRL may protect against diabetes, as suggested by the facts that PRL and PL promote the function, proliferation, and survival of -cells (166, 177, 183), and circulating PRL levels are often decreased in poorly controlled diabetic patients (260) and rats (60).”
BackgroundKondegowda, N. G., Fenutria, R., Pollack, I. R., Orthofer, M., Garcia-Ocaña, A., Penninger, J. M., & Vasavada, R. C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.021 · Cited by 169
“Type 1 (T1D) and Type 2 (T2D) diabetes result from a loss of functional pancreatic b-cell mass caused by b-cell death and dysfunction (Padgett et al., 2013; Weir and Bonner-Weir, 2013).”
InfluentialSelf-citation
Metadata
- Authors
- Fujinaka, Y., Takane, K., Yamashita, H., & Vasavada, R. C.
- Affiliations
- University of Pittsburgh (US)
- Nagoya City University (JP)
- Corresponding author
- Vasavada, Rupangi C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 282
- Issue
- 42
- Pages
- 30707-30717
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2034353384
- Cited by
- 92
- References
- 44
- Citations by year
- 2025: 7 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 9 · 2012: 4
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4739 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-072264, R01DK072264)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- lactogen, prolactin, placental lactogen, beta-cell survival, JAK2/STAT5 signaling, Bcl-xL, beta-cell death, dexamethasone, streptozotocin, insulinoma cells, islets, diabetes mellitus
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Survival, Dexamethasone, Diabetes Mellitus, Experimental, Genes, Dominant, Insulin, Mice, Transgenic, Mutation, Placental Lactogen, Prolactin, Promoter Regions, Genetic, Signal Transduction, Up-Regulation, Cell Death, Cytoprotection, RNA, Small Interfering, Cell Line, Tumor, Insulin-Secreting Cells, STAT5 Transcription Factor, bcl-X Protein, Mice, Rats, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation. https://app.cochat.ai/papers/10.1074/jbc.m702607200
- The paper
- Fujinaka, Y., Takane, K., Yamashita, H., & Vasavada, R. C. (2007). Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m702607200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.